DOCUMENT
1/1
Treatment Satisfaction of Galcanezumab in Japanese Patients With Episodic Migraine: A Phase 2 Randomized Controlled Study
media
posted on 2021-03-25, 12:21 authored by Adis journals on behalf of, Yoshihisa Tatsuoka, Takao Takeshima, Akichika Ozeki, Taka MatsumuraArticle full text
The above summary slide and graphical plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.